Absci ABSI
NASDAQ ABSI
$8.83 +0.03 (+0.34%)
As of: Sep 4, 2026 · 2:23 PM EDT

Absci (ABSI) EPS (Basic) Growth (5y) (2025 - 2026)

Analysis

Absci (ABSI) EPS (Basic) Growth (5y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn
10 Absci 1.39 Bn 1.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.49%
Mar 31, 2026 22.77%
Dec 31, 2025 10.15%
Sep 30, 2025 25.19%
Jun 30, 2025 26.48%